Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMHO the guy is making the call on his own merit and when he's correct he will be able to attract a large following based on the upside this will bring.
Gltal in the end the only thing that matters are the reserves on the property.
Drilling continued today as they were off in Mexico for Father's Day on Sunday.
More hopes drilled and more assay results expected.
Rumor is they are huge!
What are you hearing?
Correct, the money which he/she invested was completely vaporized!
Sell sell sell already!!!!
Management won't miss you, that I assure you.
News
Milestone Scientific’s Epidural & IA Subsidiary and Moss S.p.A. Sign Exclusive Distribution Agreement for Epidural Instrument in Italy
Announces Plans to Broaden U.S. Distribution Strategy
LIVINGSTON, NJ, June 10, 2015 -- Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has entered into an exclusive distribution agreement with Moss S.p.A. for distribution of the epidural instrument in Italy. Moss is one of the leading distributors of diagnostic and specialty surgery equipment in Italy.
The term of the agreement between Milestone Scientific’s Epidural & IA subsidiary and MOSS S.p.A. is three years and includes annual minimum purchases of epidural instruments and disposable kits. Milestone will provide sales literature, organize training classes and provide product, while Moss S.p.A. will be responsible for sales and marketing support, including advertising, product placement in catalogs, product displays and trade exhibits. MOSS has also committed to hiring 15 sales representatives dedicated to the sale of the epidural instrument within the first year.
Leonard Osser, Chief Executive Officer of Milestone Scientific commented, “Italy is a viable market for our epidural instrument with over 1 million epidurals administered for surgery per year and over 60,000 epidurals administered for childbirth. Since its founding in 2000, Moss has demonstrated its ability to assess market needs and to successfully address those needs with innovative products in the medical arena. Moss’ extensive distribution capabilities in Italy will benefit Milestone and we are pleased to have them as our exclusive distribution partner in the region.”
The Epidural & IA Subsidiary also announced plans to broaden its U.S. distribution strategy beyond the current focus on labor and delivery markets.
Mr. Osser continued, “While our prior distribution partner in the U.S. maintains a solid network within birthing centers across the U.S., we’ve decided after discussion with other distributors in the pain management sector that an exclusive arrangement in this arena was too limiting given the overlap between anesthesiologists in private clinics and hospitals. These practitioners have the ability to use our instrument for both labor and delivery, as well as other pain management applications. In the U.S. alone, there are 8.9 million annual procedures that fall outside of the labor and delivery segment, many in private pain management clinics. As a result, the company believes a build out of a network of regional distribution partners whose strengths include hospitals, clinics and pain management centers will give us far greater penetration in the broader U.S. market. We look forward to announcing these partnerships in the coming months and believe that this strategy will result in greater market penetration within the respective regions. At the same time, our U.S. trials are moving forward and we look forward to announcing additional milestones in the near future.”
Does anyone have an update from the meeting? Is there a new video, a prototype? Anything
What's the start time?
CUIN2 any word on how we can listen to the meeting or will the video be posted on their website?
Good weekend to all and gltal on Monday!
Viva Mexico!! And viva our gold mine uspr!
I tend to agree with you as there is room in there for the to throw that hailmary!
Let's have some fun since the board is so boring today.
By a show of hands does anyone feel they can state they are ahead of schedule at the meeting?
I do think it's possible.
Makes zero sense to put 47070 on the offer when trading is so thin, maybe el cry baby is selling.
That would make total sense come to think of it.
Just to clarify I don't think anything happens at the meeting other than them showing a new video that most likely won't even be a pr.
I do think in the next 6 to 12 months after this meeting we can possibly get snatched up by a big player.
My dear Watson I think were on to something....??
Doesn't she have someone on her staff that worked on the Covidien deal?
One day we may look back and say this was so obvious!
And who put in that 30mm in that doesn't care about the delay?
Hmmmm
But they said they were planing on getting in, not sure how or with who.
My interpretation was that they feel the current cost of robotics remains to high for hospital and patient.
Isn't our unit cheaper for both....hmm
I have a friend thats a higher up there and he told me the same thing , but added they are looking to get into robotics, but the company feels the costs are still to high.
I do think Medtronic could be out suitor.
I agree with you ORrep8, there has been a lot info put out in the last month which should have moved the stock price up but hasn't and therefore investors on this board are frustrated.
The bottom line is very few here including myself are happy at 1.36.
50,000 here
New 52 weeks high again!
Milestone Scientific Announces Approval for Listing on the NYSE MKT
News out!
Milestone Scientific's Epidural & IA Subsidiary and Fidia Farmaceutici SpA Sign MOU for Co-Development and Manufacture of Custom Intra-Articular Drug Delivery Instrument
Milestone Scientific, Inc.
45 minutes ago
????
LIVINGSTON, NJ--(Marketwired - May 27, 2015) - Milestone Scientific Inc. (MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has signed a Memorandum of Understanding (MOU) with Fidia Farmaceutici SpA, a specialty pharmaceutical company based in Italy, for the co-development and manufacture of a custom intra-articular drug delivery instrument for Fidia's hyaluronic acid formulations. Fidia is a leading producer of hyaluronic acid formulations for joint pain.
Under the terms of the MOU, upon completion of Fidia's evaluation of the technology, Milestone Scientific's Epidural & IA subsidiary and Fidia plan to enter into a co-development and manufacturing agreement. The goal is to develop a dedicated instrument and related disposables in order to optimize drug delivery and reduce pain associated with hyaluronic acid injections for joint pain. The custom instrument will be designed to deliver Fidia's selected hyaluronic acid products exclusively.
Leonard Osser, Chief Executive Officer of Milestone Scientific, commented, "Fidia Farmaceutici's focus on joint healthcare makes it an ideal partner for the intra-articular instrument, which has already received CE Mark marketing clearance in Europe. Fidia serves a large market and is one of the leading global manufacturers of hyaluronic acid formulations for intra-articular injections. Milestone's patented technologies have already demonstrated the ability to deliver painless injections. We look forward to working with Fidia as we believe our instrument will prove equally beneficial in reducing or eliminating the pain associated with the delivery of hyaluronic acid into the joints."
About Fidia Farmaceutici SpA
Fidia Farmaceutici SpA, a company belonging to the P&R Group, is a specialty pharmaceutical company whose mission, among others, is to provide, on a worldwide leadership position, whether directly or through its affiliated companies, patients with innovative products that offer quality, safety and high levels of performance. A primary focus of its product portfolio is "joint healthcare" for which it produces a number of hyaluronic acid formulations.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website: www.milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2013. The forward looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
Contact:
David Waldman or Klea Theoharis
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020
Suck it the buyer IMHO is Medtronic.
Remember this post!
More insider buying yesterday.
Very positive based in the over 2.8mm they already owned.
Great post and all true.
Drill prove and sell with a lot less dilution and a higher price
Good morning team USPR, looks like once this seller at .153 is taken out this thing is off to the races.
I see about 250,000 for sale.
Great call where do you think well close tomorrow?
Chin up balls flapping!
Lol and during that time there is also the possibility that JnJ/Google pounce.
Thanks for the trading lesson but I'll stick to warren buffets advise.
You sound like a broken record and you have been wrong before on this board very board most recently.
Now go vap and ecig the heck outta here.
Peace.
There was a 100,000 share bid at 1.30 today and yesterday.
Just checked nothing new at all.
Thanks with results coming soon that's a great idea!
When do you think we will start to see the first results released from the company?
I have heard approx 4-6 weeks?
Interesting that 100,000 traded after the close? Thoughts?
Looks like you were wrong, this one is no scam my man:
ITEM 5. OTHER INFORMATION.
Operational Update.
As mentioned herein, on February 23, 2015, we entered into an agreement with an operator for the drilling of 5,000 meters on our property located in Mexico. In this regard, preparatory roadwork began in the first week of April 2015 and actual drilling operations commenced on April 17, 2015.
Make a public apology and be real:
ITEM 5. OTHER INFORMATION.
Operational Update.
As mentioned herein, on February 23, 2015, we entered into an agreement with an operator for the drilling of 5,000 meters on our property located in Mexico. In this regard, preparatory roadwork began in the first week of April 2015 and actual drilling operations commenced on April 17, 2015.
Good work and thank you for sharing.
Good morning team uspr! Could this be a big well, time will tell, in the mean time:
Looks like this could be good for uspr finding a suitor once they drill and prove.
Another company speaking highly of Hans Hertell, very positive as well as vindicating based in some of the posts that have been made here:
Appoints Former U.S. Ambassador Hans H. Hertell to its Board of Directors [Market News Publishing (Canada)]
COLT RESOURCES INC
COLT RESOURCES INC. ("GTP-V") - Appoints Former U.S. Ambassador Hans H. Hertell to its - Board of Directors
Colt Resources Inc. announces the resignation of Mr. Wayne Murton from its Board of Directors and the appointment of Ambassador Hans H. Hertell to its Board of Directors. The Company wishes to thank Mr. Murton for having served as a director and will continue to use his services as a consultant.
Ambassador Hertell has over 30 years' experience in government, public affairs, business, and banking, He was sworn in as the United States Ambassador to the Dominican Republic on November 8, 2001. When he finished his tour in May 2007, Ambassador Hertell was the second longest serving U.S. Ambassador in the world.
Ambassador Hertell has served with distinction as officer and member of the board of directors of public and private corporations. From 1981 to 1989, and by appointment of the President of the United States, he served on the Board of Directors of the Federal Home Loan Bank of New York, a banking system created by U.S. Congress which at the time had over 1.3 trilion dollars in assets. Subsequently, Ambassador Hertell served as Chief Executive Officer and Chairman of the Board of Ponce Federal Bank (NYSE), one of the largest publicly traded corporations in the Caribbean, with $1.3 billion in assets. He also served on the Board of Directors of OCASO Insurance, a subsidiary of the largest insurance and reinsurance holding companies in Spain.
Ambassador Hertell currently serves on the Board of Directors of InterEnergy Holdings, a holding company that owns and operates power generation and distribution assets in Latin America and the Caribbean. He is also President, and Chairman of the Board of Directors of U.S. Precious Metals, Inc. (OTC NASDAQ).
President and CEO of the Company, Mr. Nikolas Perrault comments, "We are delighted to welcome Ambassador Hertell to the Board. The combination of experience and extensive global connections that he brings to Colt are impressive and we look forward to working closely with him on numerous fronts. At the same time we would like to thank Mr. Wayne Murton for his years of dedication and wish him the best on his future endeavours."
About Colt Resources Inc.
Colt Resources Inc. (www.coltresources.com) is a Canadian mining exploration and development company engaged in acquiring, exploring, and developing mineral properties with an emphasis on gold and tungsten. It is currently focused on advanced stage exploration projects in Portugal, where it is one of the largest lease holders of mineral concessions.
The Company's shares trade on the TSX-V, symbol: GTP; the Frankfurt Stock Exchange, symbol: P01; and, the OTCQX, symbol: COLTF.